• Top Picks
    • Personalized Medicine in Obesity Treatment: An In-depth Look at How to Use Today's Obesity Medications in Patients Who Need to Lose Weight
    • Improving Outcomes with SGLT2 Cotransporter Inhibitors in Challenging T2DM Patients: Updates from EASD 2013
    • Dialogues in Diabetes: Volume 3, Number 4
    • Obesity and Comorbidities: Improving Clinical Management and Patient Outcomes in Obesity and Asthma

Select a Topic

  • FILTER BY:
  • All Education Lab
  • CME Only
Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?
CME

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron.

Expiration Date: 8/28/2015
Credit Type(s): CME | Credit: 2

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates good patient awareness, timely screening and treatment. However, knowledge and…

go to activity»
Experts’ Take: Dialogue on Hypertriglyceridemia
CME

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Expiration Date: 7/21/2015
Credit Type(s): CME | Credit: 0.75

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis. This has serious consequences, as the National Health and Nutrition Examination…

go to activity»
Acromegaly: Pathophysiology, Signs,  Symptoms, and Complications - Part 1 of 5
CME

Acromegaly: Pathophysiology, Signs, Symptoms, and Complications - Part 1 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 4/24/2015
Credit Type(s): CME | Credit: 0.5

An understanding of the pathophysiological mechanisms of acromegaly is important to its various complications as well as its diagnosis and treatment. This article provides a succinct summary of the…

go to activity»
INVOKANA®: Medication Overview Video Challenge
VIDEO

INVOKANA®: Medication Overview Video Challenge

This activity is sponsored as an educational service by Janssen Pharmaceuticals, Inc.

August 21, 2014

Join Dr Richard B. Aguilar, primary care physician and a diplomate of the American Board of Internal Medicine, as he reviews INVOKANA®(canagliflozin)…

go to activity»
Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5
CME

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 5/26/2015
Credit Type(s): CME | Credit: 0.5

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is associated with multiple comorbidities and increased mortality. However, diagnosis and…

go to activity»
Acromegaly: Challenges in Diagnosis - Part 2 of 5
CME

Acromegaly: Challenges in Diagnosis - Part 2 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 4/24/2015
Credit Type(s): CME | Credit: 0.5

The diagnosis of acromegaly is often not made until 7 to 10 years after symptom onset. Contributing factors include low disease awareness among health care professionals as well as confusion with…

go to activity»